News-Medical.Net on MSN2d
Natural product derivative demonstrates promising therapeutic potential for psoriasis
Announcing a new publication for Acta Materia Medica journal. Phosphodiesterase-4 (PDE4), a member of the phosphodiesterase ...
Clinical Trials Arena on MSN11d
Palisade Bio begins dosing subjects in last cohort of ulcerative colitis drug trial
The trial’s primary objective is to assess PALI-2108’s tolerability, pharmacokinetics and safety in healthy volunteers.
AlphaGalileo2d
Moracin M derivative targeting PDE4 for the treatment of psoriasis
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
Nature5y
Enhancing cognition through PDE4 regulation
The cyclic nucleotide phosphodiesterase 4 (PDE4) regulates the hydrolysis of the second messenger cyclic AMP. cAMP is a major intracellular signalling mediator that directly affects the activity ...